株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

痔瘻:世界の治験動向

Anal Fistula Global Clinical Trials Review, H1, 2017

発行 GlobalData 商品コード 330938
出版日 ページ情報 英文 52 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.47円で換算しております。
Back to Top
痔瘻:世界の治験動向 Anal Fistula Global Clinical Trials Review, H1, 2017
出版日: 2017年03月31日 ページ情報: 英文 52 Pages
概要

当レポートでは、痔瘻の治療薬に関する治験について調査分析し、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報、治験プロファイルなどについて、体系的な情報を提供しています。

当レポートの概要

各地域における治験状況

  • 各国の治験件数と平均被験者数
    • 主要国における治験件数; アジア太平洋地域
    • 上位5ヶ国における治験件数; 欧州
    • 主要国における治験件数; 北米
    • 主要国における治験件数; 中東/アフリカ地域

G7諸国における治験件数:痔瘻治験件数の消化管疾患治験件数に対する比率

フェーズ(相)別治験件数:G7諸国

G7諸国における治験件数:フェーズ(相)別

E7諸国における治験件数:痔瘻治験件数の消化管疾患治験件数に対する比率

フェーズ(相)別治験件数:E7諸国

E7諸国における治験件数:フェーズ(相)別

フェーズ(相)別治験件数

  • フェーズ(相)別の進行中治験件数

進捗状況別の治験件数

評価項目別の治験件数

一定期間に採用された被験者数

スポンサーの種類別治験件数

有望なスポンサー

治験主要参加企業 - 痔瘻治療薬

有望な薬剤

最新治験ニュース:痔瘻

治験プロファイルの基本情報

付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次

GlobalData's clinical trial report, "Anal Fistula Global Clinical Trials Review, H1, 2017" provides an overview of Anal Fistula clinical trials scenario. This report provides top line data relating to the clinical trials on Anal Fistula. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 4
  • Report Guidance 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Countries Contributing to Clinical Trials in Asia-Pacific 10
  • Top Five Countries Contributing to Clinical Trials in Europe 11
  • Top Countries Contributing to Clinical Trials in North America 12
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 13
  • Clinical Trials by G7 Countries: Proportion of Anal Fistula to Gastrointestinal Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Anal Fistula to Gastrointestinal Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Anal Fistula Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Latest Clinical Trials News on Anal Fistula 29
  • Mar 07, 2017: TiGenix Receives Positive Feedback from the FDA on Cx601 Global Phase III Trial Protocol 29
  • Feb 17, 2017: Takeda and TiGenix Report New Data Highlighting Maintenance of Long-Term Remission of Complex Perianal Fistulas in Crohn's Disease Patients with Cx601 29
  • Clinical Trial Profile Snapshots 31

Appendix 50

  • Abbreviations 50
  • Definitions 50
  • Research Methodology 51
  • Secondary Research 51
  • About GlobalData 52
  • Contact Us 52
  • Source 52

List of Tables

  • Anal Fistula Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Anal Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 8
  • Anal Fistula Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9
  • Anal Fistula Therapeutics Clinical Trials, Asia-Pacific, Top Countries, 2017* 10
  • Anal Fistula Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11
  • Anal Fistula Therapeutics Clinical Trials, North America, Top Countries, 2017* 12
  • Anal Fistula Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 13
  • Proportion of Anal Fistula to Gastrointestinal Clinical Trials, G7 Countries (%), 2017* 14
  • Anal Fistula Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Anal Fistula Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Anal Fistula to Gastrointestinal Clinical Trials, E7 Countries (%), 2017* 17
  • Anal Fistula Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Anal Fistula Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Anal Fistula Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Anal Fistula Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Anal Fistula Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Anal Fistula Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Anal Fistula Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Anal Fistula Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Anal Fistula Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Anal Fistula Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Anal Fistula Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

  • Anal Fistula Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Anal Fistula Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Anal Fistula Therapeutics, Global, Clinical Trials In Progress by
Back to Top